1 Lecture 3: Laboratory Diagnostics in ARV Therapy delivered by Dr. Madisa Mine, Botswana Ministry of Health KITSO AIDS Training Program.

Slides:



Advertisements
Similar presentations
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Advertisements

HIV Counselling and Testing
Unit 6 Diagnosis & Follow-up of HIV Infection
CHER Trial: Early Antiretroviral Therapy and Mortality Among HIV- Infected Infants New England J Med 2008;359 (21):
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Acute Retroviral Syndrome
Ebola Virus Disease (EVD) Laboratory Diagnostics 04/12/2014.
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria.
Molecular Diagnosis of Infectious Diseases. Why use a molecular test to diagnose an infectious disease? Need an accurate and timely diagnosis Important.
Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Attending Physician Ronald Reagan Medical Center Center for World Health and Division.
Learning Objectives How to detect HIV antibodies/HIV infection?
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
HIV Testing CDC power point edited by M. Myers
Laboratory Investigation
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU August 27, 2014.
HIV Testing Quality Assurance and Quality Control
J.L.K. Fletcher, S. Pinyakorn, M. de Souza, S. Akapirat, R. Trichavaroj, T. Pankam, E. Kroon, D. Colby, P. Prueksakaew, D. Suttichom, J.H. Kim, P. Phanuphak,
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
HIV/AIDS is preventable and treatable, but is incurable.
Is monitoring for CD4 counts still needed for the management of patients with long- term HIV RNA suppression? Andrew Hill, Liverpool University, UK.
DRAFT BHIVA GUIDELINES Routine monitoring of HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
MEDICAL TESTING Doctor requires information Patient sample collection
New HIV Test Algorithms and Revised Adult HIV Case Report Form (DCH #1355) HIV Surveillance HIV/STD/VH/TB Epidemiology Section Bureau of Epidemiology Michigan.
DIAGNOSIS OF HIV INFECTION THE LABORATORY BY DR. K.BUJJIBABU.MD.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
P1 1 Summary of the training modules. P2 2 Introduction You know now what is HIV and what is AIDS. How HIV is acquired, how it causes disease what are.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.
BTY328: Viruses Dr William Stafford
HIV testing at the ICTC ICTC Team Training.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.
Clinical case 19 Lin, I-Yao (Sally). Case 19 Having been confined in the hospital for almost a month due recurrent pneumonia, Mr. XXX, 42 y/o, married,
Fifth Annual President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting September , 2007 Thomas J. Spira, M.D. International Laboratory.
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU Sept 1, 2015.
LAB. DIAGNOSIS OF VIRUSES 5 methods are used for diagnosis in the virology laboratory: 1.Direct microscopy 2.Cultivation of viruses 3.Serology 4. Detection.
Basic Principles of Phlebotomy Part II: Blood Collection Tubes CLS 424 Phlebotomy Student Lab Rotation.
Module 4: Testing and monitoring. Module 5: Testing and monitoring Module goal To introduce participants to best practice regarding the different tests,
Lesson starter Once a protein has denatured, it cannot return to its original shape. Explain why. Haemoglobin is a protein found in the blood. Name two.
SPECIAL CONSIDERATIONS August
HIV/AIDS is preventable and treatable, but is incurable.
professor in microbiology
Blood Tests (“Labs”) 1. “Labs” Regular blood tests are a crucial part of HIV health care. They are often referred to as “bloods” or “labs” Several important.
MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Immune reconstitution Anjie Zhen, PhD
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Interventions for Clients with HIV/AIDS and Other Immunodeficiencies.
 YEOH HUI SHIH –INTRODUCTION TO HIV  RAJAMANI- ELISA  TIEN WEI PING – WESTERN BLOTTING  YEO HUI YUN –OVERVIEW & CONCLUSION.
RETROVIRIDAE GENUS: ONCOVIRUS: HTLV-1 and HTLV-2 SPUMAVIRUS LENTIVIRUS: HIV-1 and HIV-2.
Cellular immune control of Human Immunodeficiency Virus (HIV) Dr. Ali Jalil Ali College of pharmacy.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
 Direct  Indirect  Direct: -Microscopy -Culture -Antigen -Nucleic acid  Indirect: -Specific antibody (Serology)
1 Module 2: HIV Counseling and Testing for PMTCT Ministry of Health/HAPCO, Ethiopia.
NAME; BEDAN W KANGETHE BSC. BIOCHEMISTRY, NPHLS NHRL.
Kingdome of Saudia Arabia Al-Majmaah University Applied of Medical Science Clinical Virology CLINICAL VIROLOGY MDL 325 Presented by : Mohammad Al- Turaqi.
HIV Human immunodeficiency Enveloped, icosahedral, single stranded linear, RNA It belongs to the Retrovirus family that is.
A REVIEW ON HIV DIAGONOSTIC TEST
Stability of whole blood over time for CD4 & Viral load determination in HIV infected persons. N. Sippy & A. Abayomi Ladymeade Reference Unit Laboratory.
In The Name of God.
LAB. DIAGNOSIS OF VIRUSES
Laboratory Diagnosis of Infectious Diseases
The Clinical Laboratory
PHARMACOTHERAPY III PHCY 510
Hiv.
Diagnosis and Management of Acute HIV
Presentation transcript:

1 Lecture 3: Laboratory Diagnostics in ARV Therapy delivered by Dr. Madisa Mine, Botswana Ministry of Health KITSO AIDS Training Program

2 Main Lab Tests in ARV Therapy HIV diagnosis: –Adults: ELISA test –Infants under 18 months: DNA PCR test Monitor viral suppression: Viral load Monitor recovery of immune system: CD4 cell count Monitor drug toxicity: chemistry and haematology ARV Resistance Assay

3 Detection of HIV Infection Antibody methods for diagnosing HIV -(ELISA) Enzyme Linked Immunosorbent Assay -Western Blot -Rapid tests DNA PCR tests p24 antigen (used to screen blood donations) HIV culture (used for research)

4 Window Period Period between infection and first reliable detection of HIV by lab test. Window period varies by test and by individual. The majority of infected individuals are positive by ELISA, antigen, and/or DNA/RNA tests by 6-8 weeks after infection.

5 Minimum Time from Infection to First Detection of HIV-1 Markers ELISA p24 DNA PCR RNA (VL) Detection of HIV: time (in days) after infection KEY: TIME WHEN HIV DETECTION BY TEST IS POSSIBLE TIME PERIOD BEFORE DETECTION Infection

6 Diagnosis in Adults In adults, diagnosis of HIV infection is best determined by the detection of antibodies (markers) to the virus in blood. The antibodies are specific for particular virus proteins and are unique to HIV.

7 ELISA Algorithm for Diagnosing HIV 2 Parallel ELISA Tests Negative Patient uninfected or in window period of infection

8 2 Parallel ELISA Test Positive Discordant Parallel ELISA Tests (positive/negative) Repeat ELISAs on same sample Positive Patient infected Western Blot Positive Indeterminate Negative Patient infected Patient uninfected or in window period of infection Re-draw blood and repeat ELISA Discordant Negative

9 Western Blot Most commonly used confirmatory test. Detects antibodies directed at specific HIV envelope and core proteins.

10 Alternative Methods of Sero-diagnosis of HIV Infection Rapid tests Non-invasive testing methods –Saliva or urine

11 Rapid Tests Quick, cheap, easy to use. Easy to store. A laboratory is not required. Combinations of rapid tests are highly sensitive and specific. However, interpretation does require trained personnel.

12 Sample Required for ELISA Five (5) milliliters of whole blood in plain or purple-top EDTA tubes. Samples should be stored in the fridge at 4 0 C and NOT frozen. Samples should be sent to the lab within 24 hours.

13 Labeling of Lab Test Tubes (all assays) Tubes should be labeled with: –PATIENT IDENTIFICATION NUMBER (ID/Omang) –Date of collection

14 Filling out Lab Test Forms (all assays) Fill in patient information: ID / Omang Patient initials (as a cross-check for errors) Patient gender (M or F) Patient date of birth (day / month / year) Fill in sample information: Date specimen drawn (day / month / year) Time specimen drawn (24 hour clock) Site information: Initials and signature or stamp of clinician

15 Diagnosis in Infants Diagnosis of HIV by serology in infants under 18 months is complicated by the presence of maternal antibodies passed along both in utero and via breast milk. Hence detection of HIV nucleic acid in infant blood is done by DNA PCR.

16 DNA PCR Assay PCR based on cellular proviral HIV DNA provides a qualitative result: Positive or Negative

17 Sample Required for DNA PCR ml of whole blood in purple-top EDTA tubes w/ anticoagulant. Tube should be mixed well by inverting slowly 5-10 times IMMEDIATELY after collection to prevent clotting. Sample should be stored in the fridge and NOT frozen. The sample should be sent to the lab immediately. Turn-around-time is 2 weeks.

18 Monitoring HIV Disease Progression

19 HIV Disease Progression Progression can be monitored by: Clinical markers: ▪ HIV/AIDS-related conditions and mortality. Laboratory markers:  Increase in blood virus levels (viral load)  Decrease in CD4 cell count

20 CD 4 and Viral Load Progression Viral load CD4 TIME Infection High Low

21 Measures the number of virus particles per ml of blood by quantifying HIV RNA. With the standard test used in Botswana, 400 – 750,000 HIV copies per ml of blood can be detected. Measure viral load at start of therapy, after 3 months and every 3 months thereafter. Viral Load

22 Sample Collection for Viral Load Collect blood in 5-7 ml EDTA anticoagulant tube for adults, 3ml tube for infants. Tube should be mixed well by inverting slowly 5-10 times IMMEDIATELY after collection to prevent clotting. Store in the 4 0 C fridge while awaiting transportation to lab. Sample should be transported to lab within 4-6 hours of collection in cool box with ice pack at 4 0 C.

23 Sample Collection for Viral Load If sample cannot reach testing labs within 6 hours, collection viral load sample in PPT tube. Local lab should centrifuge PPT tube samples to separate plasma and then ship to testing lab within 24 hours.

24 Viral Load Results Turn-around time is 2 weeks. Detection limit of assay = 400 copies/ml. Undetectable result indicates viral load below 400 copies/ml. Recent study in Botswana: –median viral load in asymptomatic patients: 36,000 copies/ml. –median viral load in AIDS patients: 296,000 copies/ml. Potential log inherent variability in viral load assay (60-80% due to biologic variation).

25 CD4 Cell Counts

26 CD4 Cell Counts CD4 cell count measures the number of CD4 cells per cubic milliliter of blood. The CD4 count is a measure of the degree of immuno-compromise and stage of HIV disease progression. The CD4 count is an important test for deciding whether ARV therapy is required and for monitoring the recovery of the immune system under treatment.

27 CD4 Counts in Botswana Uninfected : 750 cells/ul (IQR: ) Asymptomatic HIV-1 positive: 350 cells/ul (IQR: ) Patients with AIDS : 121 cells/ul (IQR: )

28 Sample Collection for CD4 Count Three (3) ml of whole blood in EDTA anticoagulant (purple top tube). Tube should be mixed well by inverting slowly 5-10 times IMMEDIATELY after collection to prevent clotting. Sample should be transported to the lab within 24 hours. Store and transport sample at room temperature: C (cool box without ice pack).

29 CD4 cell counts Turn-around time is 72 hours. Measure CD4 cell count: –As an eligibility screen for therapy. –At baseline and every 3 months on therapy. –Off-therapy: If CD4 count > 350: every 6 months. If CD4 between 201 and 349: every 3 months.

30 Interpretation of CD4 Counts Use absolute CD4 cell count in adults. Use CD4% in infants and children. Ignore CD8 count and CD4:CD8 ratio % variability in CD4 cell count due to: –biologic variation. –sampling/measurement error. Variation usually not clinically relevant.

31 Monitoring for ARV Toxicity

32 Chemistry and Haematology Before start of therapy: full blood count, liver function, kidney function, blood sugar. At start of therapy, 1 month, 3 months, then 3- monthly: –FBC –liver and kidney function –Glucose NVP-containing regimens: liver function tests are drawn two weeks after HAART initiation.

33 Samples required for chemistry and haematology tests TestsType of tubeVolume requiredComments FBCEDTA ( purple top)3 mlMix gently by inverting 5-10 times LFT Creatinine AmylasePlain/no additive Do not mix/ allow time to Proteins, CO 2 ( red top)3-5 mlClot before testing CPK, TBil Lipase Cholesterol Triglycerides HDL/LDL Plain (red) 3 mlFasting sample/clotted LactateHeparin tube on ice 3 mlMix gently by inverting 5-10 times GlucoseSodium Fluoride (Grey Top) 2 mlMix gently by inverting 5-10 times

34 Other Tests Syphilis serology (5 ml plain red-top tube). Hepatitis B antigen (5 ml plain red-top tube). –No longer part of baseline laboratory tests under Revised 2005 Guidelines.

35 Resistance Assays A genotypic resistance assay is performed for patients failing second-line therapy to determine which drugs to which a patient may no longer be susceptible. The resistance assay, combined with expert opinion, will guide treatment decisions for third line therapy. The blood sample for resistance assays should be drawn while a patient is still on the failing regimen. Or no more than four weeks after discontinuation.

36 Sample Collection for Resistance Assay Collect blood in 5-7 ml EDTA anticoagulant tube for adults, 3ml tube for infants. Tube should be mixed well by inverting slowly 5-10 times IMMEDIATELY after collection to prevent clotting. Store in the 4 0 C fridge while awaiting transportation to lab. Sample should be transported to lab within 4-6 hours of collection in cool box with ice pack at 4 0 C.

37 Sample Collection for Resistance Assay If sample cannot reach testing labs within 6 hours, collection viral load sample in PPT tube. Local lab should centrifuge PPT tube samples to separate plasma and then ship to testing lab within 24 hours.

38 Summary HIV diagnosis: –Adults: ELISA test –Infants under 18 months: DNA PCR test Monitor viral suppression: Viral load Monitor recovery of immune system: CD4 cell count Monitor drug toxicity: chemistry and haematology ARV Resistance Assay